148 related articles for article (PubMed ID: 32930130)
1. Evaluation of the relationship between serum ghrelin levels and cancer cachexia in patients with locally advanced nonsmall-cell lung cancer treated with chemoradiotherapy.
Uysal P; Afsar CU; Sozer V; Inanc B; Agaoglu F; Gural Z; Fazlıoglu NY; Cuhadaroglu C; Uzun H
J Cancer Res Ther; 2020; 16(4):855-859. PubMed ID: 32930130
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.
Karapanagiotou EM; Polyzos A; Dilana KD; Gratsias I; Boura P; Gkiozos I; Syrigos KN
Lung Cancer; 2009 Dec; 66(3):393-8. PubMed ID: 19282046
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
[TBL] [Abstract][Full Text] [Related]
4. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy.
Palomar-Abril V; Soria-Comes T; Campos ST; Ureste MM; Bosch VG; Maiques ICM
Clin Transl Oncol; 2020 Dec; 22(12):2333-2340. PubMed ID: 32449125
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the relationship of erythrocyte membrane Na+/K+-ATPase enzyme activity and tumor response to chemoradiotherapy in patients diagnosed with locally advanced nonsmall cell lung cancer and glioblastoma multiforme.
Cetinkaya CD; Gurbilek M; Koc M
J Cancer Res Ther; 2018 Jun; 14(Supplement):S450-S456. PubMed ID: 29970705
[TBL] [Abstract][Full Text] [Related]
6. Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer.
Shirasawa M; Yoshida T; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Yamamoto N; Watanabe SI; Ohe Y; Motoi N
Eur J Cancer; 2020 Nov; 140():28-36. PubMed ID: 33039811
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α Levels in patients receiving chemoradiotherapy for locally advanced non-small cell lung carcinoma.
Afsar CU; Uysal P
Rev Assoc Med Bras (1992); 2019; 65(10):1295-1299. PubMed ID: 31721962
[TBL] [Abstract][Full Text] [Related]
8. Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy.
Hoffmann M; Reitz D; Taugner J; Roengvoraphoj O; Käsmann L; Eze C; Karin M; Belka C; Manapov F
Anticancer Res; 2020 Apr; 40(4):2319-2322. PubMed ID: 32234932
[TBL] [Abstract][Full Text] [Related]
9. Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.
Lan WG; Hao YZ; Xu DH; Wang P; Zhou YL; Ma LB
Clin Transl Oncol; 2016 Apr; 18(4):375-80. PubMed ID: 26329292
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment Glasgow prognostic score in stage IIIB geriatric non-small cell lung cancer patients undergoing radical chemoradiotherapy.
Topkan E; Bolukbasi Y; Ozdemir Y; Besen AA; Mertsoylu H; Selek U
J Geriatr Oncol; 2019 Jul; 10(4):567-572. PubMed ID: 31178158
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the cachexia index in patients with small cell lung cancer.
Go SI; Park MJ; Lee GW
BMC Cancer; 2021 May; 21(1):563. PubMed ID: 34001060
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Jo H; Yoshida T; Horinouchi H; Yagishita S; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Yamamoto N; Takahashi K; Motoi N; Ohe Y
Cancer Immunol Immunother; 2022 Feb; 71(2):387-398. PubMed ID: 34180007
[TBL] [Abstract][Full Text] [Related]
13. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
[TBL] [Abstract][Full Text] [Related]
14. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
15. Definitive concurrent chemoradiotherapy outcomes in Stage IIIB nonsmall cell lung cancer patients younger than 45 years: A retrospective analysis of 145 patients.
Topkan E; Guler OC; Ozdemir Y
J Cancer Res Ther; 2020; 16(4):757-763. PubMed ID: 32930115
[TBL] [Abstract][Full Text] [Related]
16. Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Fukui T; Hosotani S; Soda I; Ozawa T; Kusuhara S; Kakegawa MI; Kasajima M; Hiyoshi Y; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Ishiyama H; Naoki K
Thorac Cancer; 2020 Apr; 11(4):1005-1014. PubMed ID: 32057187
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
Atagi S; Mizusawa J; Ishikura S; Takahashi T; Okamoto H; Tanaka H; Goto K; Nakagawa K; Harada M; Takeda Y; Nogami N; Fujita Y; Kasai T; Kishi K; Sawa T; Takeda K; Tomii K; Satouchi M; Seto T; Ohe Y
Clin Lung Cancer; 2018 Sep; 19(5):e619-e627. PubMed ID: 29887243
[TBL] [Abstract][Full Text] [Related]
18. Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Willemsen ACH; Degens JHRJ; Baijens LWJ; Dingemans AC; Hoeben A; Hoebers FJP; De Ruysscher DKM; Schols AMWJ
Front Nutr; 2020; 7():600612. PubMed ID: 33324671
[No Abstract] [Full Text] [Related]
19. Adipokines and ghrelin in gastric cancer cachexia.
Kerem M; Ferahkose Z; Yilmaz UT; Pasaoglu H; Ofluoglu E; Bedirli A; Salman B; Sahin TT; Akin M
World J Gastroenterol; 2008 Jun; 14(23):3633-41. PubMed ID: 18595130
[TBL] [Abstract][Full Text] [Related]
20. Nesfatin-1 in advanced lung cancer patients with weight loss.
Cetinkaya H; Karagöz B; Bilgi O; Ozgün A; Tunçel T; Emirzeoğlu L; Top C; Kandemir EG
Regul Pept; 2013 Feb; 181():1-3. PubMed ID: 23269222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
